beta
(영문) 서울중앙지방법원 2016.12.09 2015나68477

손해배상(자)

Text

1. Of the judgment of the court of first instance, the part against the plaintiff corresponding to the money ordered to pay below shall be revoked.

The defendant.

Reasons

1. The reasoning of the court's explanation concerning this case is as follows, and this part of the judgment of the court of first instance is as stated in the reasoning of the judgment of the court of first instance, except where part of the judgment of the court of first instance is used as follows. Thus, this is accepted in accordance with the main sentence of Article 420

2. The “attached Form 1 Statement of Compensation Calculation” in Section 8 of the judgment of the court of first instance shall be replaced by the following table:

The "attached Form 2 calculation table of the supplementary Gu" in the 9th judgment of the first instance shall be replaced by the following table:

4. Grounds for the decision of the first instance;

A. 1) The Plaintiff’s personal information is written as follows. 1) The Plaintiff’s personal information is as indicated in the column for the “basic matters” in the annexed sheet for calculation of damages: Provided, That the Plaintiff’s life expectancy is presumed to be reduced by 30% on the basis of the date of physical assessment of the first instance court ( April 7, 2015), compared with the normal person, the remaining life expectancy shall be deemed to be until October 7, 2049. The remaining life expectancy shall be deemed to be the end of October 7, 2049. 4 pages 16 of the judgment of the first instance court.

"B. W. W. W. W. W. W. W. W. W. W. W.W. W.W.W. W.W.W.W.W.W.W.W.W.W.W.W.W.W.W.W. 1,238,920, W.W.W.

“The future treatment costs: The details in the calculation table of the future treatment costs are as shown in attached Form 3. 1. The treatment costs are as indicated in the table: 261,562,473 won each year for rehabilitation treatment, etc. during the remaining life period of the Plaintiff. However, there is no evidence to acknowledge that the Plaintiff paid the future treatment costs with the new outpatient during the period from October 26, 2016 to the date of the closing of the party hearing. Thus, the treatment costs shall be calculated as spent at intervals of one year from October 26, 2016, which is the day following the date of closing of the party hearing.

2) Burinology: A total of KRW 58,514,391 (hereinafter referred to as “burinology”) KRW 2,550,624 per year with regard to pharmacologic treatment, optical function test, urinology test, urinology test, and urinology in relation to urinology in total, KRW 58,514,391, and KRW 2,550 per year with regard to urinology in total, and two times with regard to urinology (hereinafter referred to as “urinology”)